Outset Medical Announces Primary and Secondary Offering of Common Stock
Published
Apr 06 2021 at 8:35 PM GMT
Key
Points
Points
- (NASDAQ:OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, announced today the commencement of a proposed underwritten public offering of 2,500,000 shares of its common stock by Outset and 2,500,000 shares of its common stock by certain of its stockholders.
- In addition, Outset and such selling stockholders expect to grant the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock in the offering.
- The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
- Morgan Stanley, BofA Securities and Goldman Sachs & Co.
- LLC are acting as joint lead book-running managers for the offering.
Trending
Stats
- Published Apr 6, 2021 8:35 PM GMT